Literature DB >> 7662575

Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses.

P Collins1, J Ferguson.   

Abstract

Twenty patients with photodermatoses [actinic prurigo (n = 6), hydroa vacciniforme (n = 4), idiopathic solar urticaria (n = 1), amiodarone-induced photosensitivity (n = 1) and a range of cutaneous porphyrias (n = 8)] were treated with a 'hardening' course of narrow-band ultraviolet B (TL-01) phototherapy in springtime. The response to phototherapy was monitored subjectively, by interviewing patients after the summer, and objectively by monochromator phototesting, before and after phototherapy. Fifteen patients reported that treatment was worthwhile. Monochromator phototesting after phototherapy revealed a fourfold increase in the minimal erythema dose in those with abnormal photosensitivity to ultraviolet A wavebands. Adverse effects included erythema (seven patients), pruritus (five) and provocation of the eruption (four). We now routinely consider narrow-band UVB phototherapy for problem photodermatoses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662575     DOI: 10.1111/j.1365-2133.1995.tb16955.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Guidelines for the use of phototherapy and photochemotherapy in Ireland.

Authors:  G M Murphy; P McCann; A O'Leary; S Rogers
Journal:  Ir J Med Sci       Date:  1997 Apr-Jun       Impact factor: 1.568

Review 2.  Drug-induced photosensitivity: culprit drugs, management and prevention.

Authors:  Aaron M Drucker; Cheryl F Rosen
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

3.  A retrospective review of phototherapy in children, at a tertiary paediatric dermatology unit.

Authors:  Ella Seccombe; Matthew David Wynne; Cornelius Clancy; Keith M Godfrey; Adam Fityan
Journal:  Photodermatol Photoimmunol Photomed       Date:  2020-10-04       Impact factor: 3.135

4.  Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal.

Authors:  Elisabeth I Minder; Xiaoye Schneider-Yin; Christoph E Minder
Journal:  Health Qual Life Outcomes       Date:  2010-06-21       Impact factor: 3.186

Review 5.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

6.  Modern aspects of phototherapy for atopic dermatitis.

Authors:  Sonja Alexandra Grundmann; Stefan Beissert
Journal:  J Allergy (Cairo)       Date:  2011-12-15

7.  Seven- and 23-year-old Siblings with Papulonodular Lesions after Sun Exposure: A Quiz.

Authors:  Davide Neri; Karola Maria Stieler; Annika Vogt; Kamran Ghoreschi; Ulrike Blume-Peytavi
Journal:  Acta Derm Venereol       Date:  2021-07-30       Impact factor: 3.875

Review 8.  Cutaneous adverse reactions of amiodarone.

Authors:  Krzysztof Jaworski; Irena Walecka; Lidia Rudnicka; Maciej Gnatowski; Dariusz A Kosior
Journal:  Med Sci Monit       Date:  2014-11-21

Review 9.  An overview of the cutaneous porphyrias.

Authors:  Robert Dawe
Journal:  F1000Res       Date:  2017-10-30

10.  A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy.

Authors:  Sally H Ibbotson
Journal:  Front Med (Lausanne)       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.